Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India · Delayed Price · Currency is INR 16.08
-0.50 (-3.02%)
At close: Aug 21, 2026
BOM:531015 Market Cap
BOM:531015 has a market cap or net worth of 186.25 million as of August 21, 2026. Its market cap has increased by 22.17% in one year.
Market Cap
186.25M
Enterprise Value
180.14M
Revenue
92.94M
Ranking
n/a
PE Ratio
65.81
Stock Price
16.08
ChartMarket Cap Chart
Since April 15, 2008, BOM:531015's market cap has increased from 32.40M to 186.25M, an increase of 474.88%. That is a compound annual growth rate of 9.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 186.25M | 42.49% |
| Dec 31, 2025 | 130.71M | 38.30% |
| Dec 31, 2024 | 94.51M | 357.87% |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Smruthi Organics | 1.39B |
| Kimia Biosciences | 1.29B |
| Krebs Biochemicals & Industries | 1.17B |
| Tyche Industries | 1.06B |
| Vasundhara Rasayans | 489.44M |
| Crestchem | 377.55M |
| Alfavision Overseas (India) | 354.35M |
| Ishita Drugs and Industries | 227.26M |